Cell Biology, Genetics, and Biochemistry of Giardia
Project Number1R01AI048082-01A2
Contact PI/Project LeaderSAMUELSON, JOHN C.
Awardee OrganizationBOSTON UNIVERSITY MEDICAL CAMPUS
Description
Abstract Text
DESCRIPTION (provided by the applicant): Giardia lamblia is an amitochondriate, binucleate protist that causes diarrhea in the U.S. and the developing world. Our preliminary results make numerous important contributions to the understanding of the cell biology, genetics, and biochemistry of G. iamblia. Cell biology: Nuclear membranes remain intact during cell division. Giardia divides with mirror image symmetry in the plane of the adherence disc. Pairs of nuclei of dividing giardia are tethered together by arrays of microtubules. The Giardia [2Fe-2S] ferredoxin has an organelle-targeting sequence. Genetics: The GS strain, which was used to prove Koch's postulates, has symmetric nuclei that are each diploid. The WB strain, which is presently being sequenced, has asymmetric nuclei that are a mixture of monosomic and trisomic chromosomes. Four copies of each Giardia gene all have the same sequence. Giardia lack most of the machinery for sex. Giardia have a spliceosomal intron. Biochemistry: Genes encoding the majority of Giardia fermentation enzymes were laterally transferred from anaerobic prokaryotes. Giardia contain genes encoding nitroreductases, which are similar to those that activate metronidazole in bacteria. Giardia have an Fe-hydrogenase. These results suggest multiple hypotheses that will be tested in three Specific Aims. Major hypothesis for Aim 1 (cell biology): Perinuclear microtubules tether together pairs of nuclei of dividing Giardia, so nuclei are correctly distributed to mother and daughter Giardia. Major hypotheses for Aim 2 (genetics): Giardia are tetraploid but sequence like haploids; symmetric diplomonad nuclei are diploid for each chromosome (like GS); while asymmetric diplomonad nuclei have a mixture of monosomic and trisomic chromosomes (like WB). Minor hypothesis: Giardia are capable of splicing heterologous introns. Major hypothesis for Aim 3 (biochemistry): Giardia is sensitive to metronidazole and furazolidone, because of the presence of nitroreductases, like those of anaerobic bacteria, which reduce and activate these drugs.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Giardiacell cyclechromosome movementconfocal scanning microscopydiploidyfluorescence microscopyfluorescent in situ hybridizationgenetic straingenetic transcriptiongreen fluorescent proteinsmicrotubulesmitogen activated protein kinasenuclear membraneparasitismpolymerase chain reactionvideo microscopy
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
604483045
UEI
FBYMGMHW4X95
Project Start Date
15-February-2003
Project End Date
31-January-2008
Budget Start Date
15-February-2003
Budget End Date
31-January-2004
Project Funding Information for 2003
Total Funding
$363,375
Direct Costs
$225,000
Indirect Costs
$138,375
Year
Funding IC
FY Total Cost by IC
2003
National Institute of Allergy and Infectious Diseases
$363,375
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01AI048082-01A2
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01AI048082-01A2
Patents
No Patents information available for 1R01AI048082-01A2
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01AI048082-01A2
Clinical Studies
No Clinical Studies information available for 1R01AI048082-01A2
News and More
Related News Releases
No news release information available for 1R01AI048082-01A2
History
No Historical information available for 1R01AI048082-01A2
Similar Projects
No Similar Projects information available for 1R01AI048082-01A2